U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06840470) titled 'Investigating the Effect of Topical Imiquimod on Sebaceous Hyperplasia' on Feb. 17.
Brief Summary: This study is being completed to determine if 8 weeks of treatment with imiquimod can shrink sebaceous hyperplasia.
Study Start Date: March, 2025
Study Type: INTERVENTIONAL
Condition:
Sebaceous Hyperplasia
Intervention:
DRUG: Imiquimod 5% Topical Cream
Participants will apply this cream to one side of the face 3 times a week for up to 8 weeks. The cream will be applied before bedtime. The imiquimod should be washed off with mild soap and water after 6-10 hours. Participants will have baseline and follow-up visits that will inclu...